Concepedia

Andréia Miranda

AM

Statistics

Publications

4

Citations

103

H-Index

4

Active since

2013

Affiliations

Instituto Português de Oncologia Francisco Gentil(Current)

Fernando Pessoa University

Universidade do Porto

Rede de Química e Tecnologia

University of Aveiro

Andréia Miranda is an author at Instituto Português de Oncologia Francisco Gentil specializing in immunotherapy, vaccination, and immunology.

ORCID

Top concepts

Publications per year

2013–2024

4

Publications

4

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

Cristiana Gaiteiro, Janine Soares, Marta Relvas‐Santos et al. · Theranostics · 2022 · 41 citations · Full text

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

Luís Lima, Paulo F. Severino, Manuela Silva et al. · British Journal of Cancer · 2013 · 38 citations · Full text

A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy

Rui Freitas, Andréia Miranda, Dylan Ferreira et al. · Journal of Controlled Release · 2024 · 12 citations

, , +4

Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy

Rui Freitas, Eduardo Ferreira, Andréia Miranda et al. · ACS Nano · 2024 · 12 citations

1–4 of 4